Vivozon Pharmaceutical Co., Ltd. (KOSDAQ:082800)

Vivozon Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 5, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	226,689	339,731	144,635	149,085	186,048	296,774
Market Cap Growth	-40.07%	134.89%	-2.99%	-19.87%	-37.31%	18.74%
Enterprise Value	260,648	367,642	174,909	188,576	192,882	339,521
Last Close Price	4575.00	6529.95	2847.36	3022.95	5196.43	10013.22
PS Ratio	3.41	3.88	2.03	2.89	3.23	6.81
PB Ratio	2.58	3.19	1.39	1.44	2.15	2.66
P/TBV Ratio	2.70	3.32	1.46	1.52	2.43	4.76
P/FCF Ratio	-	-	-	-	-	79.03
P/OCF Ratio	-	59.28	48.35	-	-	64.17
EV/Sales Ratio	3.93	4.20	2.45	3.66	3.35	7.79
EV/EBITDA Ratio	-	208.45	22.04	-	-	-
EV/EBIT Ratio	-	-	37.14	-	-	-
EV/FCF Ratio	-31.46	-	-	-	-	90.41
Debt / Equity Ratio	0.45	0.34	0.40	0.58	0.97	0.97
Debt / EBITDA Ratio	-	20.70	5.24	-	-	-
Debt / FCF Ratio	-	-	-	-	-	28.87
Asset Turnover	0.38	0.49	0.40	0.27	0.26	0.21
Inventory Turnover	1.97	2.59	3.31	2.21	2.62	4.67
Quick Ratio	0.08	0.14	0.27	0.45	0.87	0.92
Current Ratio	0.49	0.62	0.70	0.60	1.08	1.06
Return on Equity (ROE)	-29.63%	-10.13%	-2.13%	-28.26%	-71.69%	-39.98%
Return on Assets (ROA)	-7.08%	-0.63%	1.63%	-3.21%	-5.54%	-2.43%
Return on Capital Employed (ROCE)	-19.20%	-1.60%	4.30%	-9.10%	-18.60%	-5.90%
Earnings Yield	-12.51%	-2.94%	-2.32%	-26.77%	-37.33%	-14.74%
FCF Yield	-3.65%	-0.80%	-1.06%	-6.58%	-14.84%	1.26%
Buyback Yield / Dilution	-7.35%	-0.06%	-9.69%	-33.41%	-24.52%	-24.63%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.